AntibodySystem는 Primary Antibody Biosimilar - Research Grade 

제품을 전문적으로 생산하는 20년의 경험이 있는 High Quality 제조사입니다. 

제품 설명 

Research Grade Lesofavumab

제품 번호

DVV03805

제품 특징

Description

Lesofavumab is a Recombinant monoclonal antibody to Influenza B virus hemagglutinin. Lesofavumab is a human monoclonal antibody that can be potentially used in the treatment of Influenza B infection. Genentech, a subsidiary of Roche, is developing lesofavumab (RG 6024), a monoclonal antibody, for the treatment of influenza B infections.

Catalog No.

DVV03805

Host species

Human

Species reactivity

Influenza B virus

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Concentration

1 mg/ml

Purity

>95% by SDS-PAGE.

Clonality

Monoclonal

Isotype

IgG1, kappa

Applications

Research Grade Biosimilar

Target

HA/Hemagglutinin

Purification

Protein A/G purified from cell culture supernatant.

Endotoxin level

Please contact with the lab for this information.

Expression system

XtenCHO

Accession

P03461

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

RG6024, RG 6024, MHAB5553A, RG70026, RO7045557, CAS: 1807960-57-1, Influenza Virus (Flu)

Note

For research use only. Not suitable for clinical or therapeutic use.

Data Image

• 

  SDS-PAGE
  SDS PAGE for Lesofavumab
• 

  SEC-HPLC
  The purity of this product is >95% as determined by SEC-MALS.

AntibodySystem의 모든 제품들을 만나 보세요!  

Products

Recombinant Protein

Antibody

Assay Kit

Research Biosimilar

{ const originalImageSrc = iconImages[index].src; li.addEventListener('mouseenter', () => { iconImages[index].src = originalImageSrc.replace('.png', '_w.png'); }); li.addEventListener('mouseleave', () => { iconImages[index].src = originalImageSrc; }); }); function goBack(){ window.history.back(); }